Alvina Widhani

1.9k total citations · 1 hit paper
35 papers, 1.0k citations indexed

About

Alvina Widhani is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Alvina Widhani has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Health. Recurrent topics in Alvina Widhani's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis B Virus Studies (5 papers). Alvina Widhani is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis B Virus Studies (5 papers). Alvina Widhani collaborates with scholars based in Indonesia, Malaysia and Australia. Alvina Widhani's co-authors include Evy Yunihastuti, Bramantya Wicaksana, Widayat Djoko Santoso, Gurmeet Singh, Mira Yulianti, Adityo Susilo, Leonard Nainggolan, Erni Juwita Nelwan, Cleopas Martin Rumende and Ceva Wicaksono Pitoyo and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ Open and Cells.

In The Last Decade

Alvina Widhani

29 papers receiving 900 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronavirus Disease 2019: Tinjauan Literatur Terkini

2020 777 citations Mira Yulianti, Alvina Widhani et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Alvina Widhani

Since Specialization

Citations

This map shows the geographic impact of Alvina Widhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvina Widhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvina Widhani more than expected).

Fields of papers citing papers by Alvina Widhani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alvina Widhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvina Widhani. The network helps show where Alvina Widhani may publish in the future.

Co-authorship network of co-authors of Alvina Widhani

This figure shows the co-authorship network connecting the top 25 collaborators of Alvina Widhani. A scholar is included among the top collaborators of Alvina Widhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvina Widhani. Alvina Widhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decline in estimated glomerular filtration rate following substitution of Nevirapine-based regimen with Tenofovir-based regimen in Indonesia 2025 ·BMC Infectious Diseases ·Evy Yunihastuti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mira Yulianti, Alvina Widhani, (unknown), (unknown), (unknown), Sukamto Koesnoe, (unknown)	0
2	Cognitive impairment in systemic lupus erythematosus patients: prevalence and its association with quality of life 2025 ·BMC Rheumatology ·(unknown), Alvina Widhani, Riwanti Estiasari, Sukamto Koesnoe, (unknown), Suryo Anggoro Kusumo Wibowo, Pradana Soewondo, Hamzah Shatri, (unknown), (unknown), Aulia Rizka	1
3	Association between immune system parameter and clinical characteristics among patients with solid cancer 2024 ·Medical Journal of Indonesia ·(unknown), Alvina Widhani, (unknown), (unknown)	0
4	Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers 2023 ·Vaccines ·(unknown), Sukamto Koesnoe, Alvina Widhani, (unknown), Hamzah Shatri, (unknown), Evy Yunihastuti, Pradana Soewondo, (unknown), Samsuridjal Djauzi, (unknown), (unknown), (unknown), (unknown)	2
5	Ramadan fasting reduces high-sensitivity C-reactive protein among HIV-infected patients receiving antiretroviral therapy 2023 ·Frontiers in Nutrition ·Alvina Widhani, Evy Yunihastuti, Siti Setiati, (unknown), (unknown)	4
6	COVID-19 Vaccination Intention in Patients with Autoimmune Diseases in Indonesia: An Application of the Integrated Behavioural Model 2023 ·Tropical Medicine and Infectious Disease ·Alvina Widhani, (unknown), (unknown), Sukamto Koesnoe, (unknown), Evy Yunihastuti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Iris Rengganis, Samsuridjal Djauzi	1
7	The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity 2023 ·BMC Psychiatry ·Hamzah Shatri, (unknown), (unknown), Robert Sinto, Alvina Widhani, (unknown), (unknown), (unknown), Chyntia Olivia Maurine Jasirwan	4
8	Survei Kebutuhan Edukasi Pasien Lupus Eritematosus Sistemik 2023 ·SHILAP Revista de lepidopterología ·(unknown), Alvina Widhani, (unknown), (unknown)	0
9	Factors Related to Severity, Hospitalization, and Mortality of COVID-19 Infection among Patients with Autoimmune Diseases 2023 ·Tropical Medicine and Infectious Disease ·Alvina Widhani, Sukamto Koesnoe, (unknown), (unknown), (unknown), (unknown), Evy Yunihastuti, Iris Rengganis, Samsuridjal Djauzi	2
10	Effectiveness of transcranial direct current stimulation (tDCS) as adjunctive treatment for chronic headache in adults with clinically stable systemic lupus erythematosus (SHADE): a randomised double-blind multiarm sham controlled clinical trial 2023 ·BMJ Open ·Riwanti Estiasari, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alvina Widhani, (unknown)	0
11	Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel 2022 ·Vaccines ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alvina Widhani, (unknown), (unknown), (unknown), (unknown)	4
12	Incidence and severity prediction score of COVID-19 in people living with HIV (SCOVHIV): experience from the first and second waves of the pandemic in Indonesia 2022 ·AIDS Research and Therapy ·Evy Yunihastuti, (unknown), Alvina Widhani, (unknown), (unknown), (unknown), Sukamto Koesnoe, Samsuridjal Djauzi	2
13	Evaluation of SARS-CoV-2 Antibody Response Post Third Dose COVID-19 mRNA Vaccination at Universitas Indonesia Hospital 2022 ·Acta Medica Academica ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alvina Widhani, (unknown), (unknown), Siti Nur Azizah, (unknown), (unknown), (unknown)	3
14	Using Integrative Behavior Model to Predict COVID-19 Vaccination Intention among Health Care Workers in Indonesia: A Nationwide Survey 2022 ·Vaccines ·Sukamto Koesnoe, (unknown), (unknown), Evy Yunihastuti, (unknown), Alvina Widhani, (unknown), (unknown), (unknown), Iris Rengganis, Samsuridjal Djauzi	12
15	Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus 2021 ·Health and Quality of Life Outcomes ·Evy Yunihastuti, (unknown), (unknown), Bramantya Wicaksana, (unknown), Alvina Widhani, Andri Sanityoso Sulaiman, (unknown)	2
16	Needlestick and sharps injuries in an Indonesian tertiary teaching hospital from 2014 to 2017: a cohort study 2020 ·BMJ Open ·Evy Yunihastuti, (unknown), (unknown), (unknown), Alvina Widhani, Andri Sanityoso Sulaiman, (unknown), (unknown)	9
17	Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients 2020 ·BMC Infectious Diseases ·Evy Yunihastuti, Bramantya Wicaksana, (unknown), (unknown), (unknown), (unknown), Alvina Widhani, Andri Sanityoso Sulaiman, (unknown)	8
18	Factors Related to Knowledge, Perception, and Practices Towards COVID-19 Among Patients with Autoimmune Diseases: A Multicenter Online Survey. 2020 ·PubMed ·Alvina Widhani, Iris Rengganis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Evy Yunihastuti, (unknown), (unknown), Sukamto Koesnoe, (unknown), (unknown), Riwanti Estiasari, (unknown), (unknown)	3
19	Serokonversi Hepatitis C pada Pasien Hemodialisis di Rumah Sakit Cipto Mangunkusumo 2017 ·SHILAP Revista de lepidopterología ·Alvina Widhani, Aida Lydia, Rino Alvani Gani, Siti Setiati	2
20	Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management 2014 ·Asia Pacific Allergy ·Evy Yunihastuti, Alvina Widhani, (unknown)	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact